Skip to content

Drug interactions

Enzalutamide + Tucatinib

Severity: Major

Enzalutamide and Tucatinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enzalutamide is expected to reduce tucatinib exposure through CYP3A4 induction, while tucatinib may increase enzalutamide levels through CYP3A inhibition. The net effect is reduced tucatinib efficacy and possible enzalutamide toxicity such as seizures.

What this interaction means in plain words

Enzalutamide and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Enzalutamide induces CYP3A4 lowering tucatinib; tucatinib inhibits CYP3A raising enzalutamide.

What to do

Avoid concomitant use. If unavoidable, monitor for loss of tucatinib efficacy and enzalutamide adverse effects, reducing the enzalutamide dose as labeling recommends.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enzalutamide and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Enzalutamide with Tucatinib?

MediHelp rates the interaction as major. Enzalutamide and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide is expected to reduce tucatinib exposure through CYP3A4 induction, while tucatinib may increase enzalutamide levels through CYP3A inhibition. The net effect is reduced tucatinib efficacy and possible enzalutamide toxicity such as seizures.

How serious is the interaction between Enzalutamide and Tucatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concomitant use. If unavoidable, monitor for loss of tucatinib efficacy and enzalutamide adverse effects, reducing the enzalutamide dose as labeling recommends.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in